{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-24-000086","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.155535+00:00","generated_at":"2026-05-30T04:37:52.096093+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keros CEO to present at Guggenheim Healthcare Innovation Conference on Nov 13","bullets":["CEO Jasbir Seehra will speak at the Guggenheim Healthcare Innovation Conference on November 13, 2024 at 3:30 p.m. ET.","A live webcast will be available at wsw.com/webcast/guggen/kros/1967811; replay for 90 days on ir.kerostx.com.","No financial results or material business updates were disclosed in the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-24-000086","json":"https://secwatch.observer/filing/0001664710-24-000086.json","markdown":"https://secwatch.observer/filing/0001664710-24-000086.md","text":"https://secwatch.observer/filing/0001664710-24-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/0001664710-24-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/kros-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:37:52.096093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}